Pediatrix Medical Group, Inc. (NYSE:MD) Shares Sold by Algert Global LLC

Algert Global LLC lessened its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 49.0% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 57,835 shares of the company's stock after selling 55,600 shares during the period. Algert Global LLC owned 0.07% of Pediatrix Medical Group worth $759,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Barclays PLC boosted its position in Pediatrix Medical Group by 302.9% during the third quarter. Barclays PLC now owns 142,087 shares of the company's stock valued at $1,646,000 after buying an additional 106,817 shares during the period. Franklin Resources Inc. purchased a new position in shares of Pediatrix Medical Group during the third quarter valued at about $598,000. Harbor Capital Advisors Inc. lifted its stake in shares of Pediatrix Medical Group by 11.9% in the 4th quarter. Harbor Capital Advisors Inc. now owns 53,717 shares of the company's stock valued at $705,000 after purchasing an additional 5,712 shares during the period. Ritholtz Wealth Management bought a new position in shares of Pediatrix Medical Group in the 4th quarter worth about $182,000. Finally, SG Americas Securities LLC purchased a new position in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $171,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Performance

Shares of Pediatrix Medical Group stock traded down $0.17 during trading on Wednesday, reaching $14.25. The company's stock had a trading volume of 1,195,891 shares, compared to its average volume of 851,574. The firm has a market cap of $1.22 billion, a PE ratio of -11.87, a P/E/G ratio of 1.74 and a beta of 1.26. The company has a 50-day moving average price of $13.69 and a two-hundred day moving average price of $14.07. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. During the same quarter in the prior year, the firm earned $0.20 EPS. Pediatrix Medical Group's quarterly revenue was down 7.4% on a year-over-year basis. On average, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analysts Forecast Growth

MD has been the subject of a number of research analyst reports. Truist Financial reduced their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Macquarie lifted their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. UBS Group dropped their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a report on Monday. Finally, StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $16.67.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.